.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Citi
Dow
Novartis
McKinsey
Fuji
Fish and Richardson
Medtronic
Teva

Generated: December 18, 2017

DrugPatentWatch Database Preview

DEPO-MEDROL Drug Profile

« Back to Dashboard

Which patents cover Depo-medrol, and when can generic versions of Depo-medrol launch?

Depo-medrol is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And UpjohnDEPO-MEDROLmethylprednisolone acetateINJECTABLE;INJECTION011757-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnDEPO-MEDROLmethylprednisolone acetateINJECTABLE;INJECTION011757-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnDEPO-MEDROLmethylprednisolone acetateINJECTABLE;INJECTION011757-004Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Johnson and Johnson
Accenture
Federal Trade Commission
Chubb
Merck
Novartis
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot